2341 Tumor genotyping and clonal evolution in KIT during regorafenib treatment in the phase III GRID study of regorafenib vs placebo in tyrosine kinase inhibitor (TKI)-refractory GIST

• 期刊名称European Journal of Cancer
• 作者Jeffers, M.; Beckmann, G.; Reischl, J.; Rutstein, M.; Wagner, A.; Demetri, G.D.; Teufel, M.
• 卷第51卷
• 印刷ISSN0959-8049
• 文件大小58.87KB
• 发表时间2015-09
• DOI10.1016/s0959-8049(16)31257-6